1. Agents in early development for treatment of bladder dysfunction – promise of drugs acting at TRP channels?. (2nd September 2019) Authors: Andersson, Karl-Erik Journal: Expert opinion on investigational drugs Issue: Volume 28:Number 9(2019) Page Start: 749 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Determinates of muscle precursor cell therapy efficacy in a nonhuman primate model of intrinsic urinary sphincter deficiency. Issue 1 (December 2017) Authors: Williams, James; Dean, Ashley; Lankford, Shannon; Criswell, Tracy; Badlani, Gopal; Andersson, Karl-Erik Journal: Stem cell research & therapy Issue: Volume 8:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and Initial Safety Profile of CXCL12 Treatment in a Rodent Model of Urinary Sphincter Deficiency. (17th July 2017) Authors: Koudy Williams, J.; Dean, Ashley; Lankford, Shannon; Andersson, Karl-Erik Journal: Stem cells translational medicine Issue: Volume 6:Number 8(2017) Page Start: 1740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Emerging drugs for the treatment of bladder storage dysfunction. (3rd July 2022) Authors: Andersson, Karl-Erik Journal: Expert opinion on emerging drugs Issue: Volume 27:Number 3(2022) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Hormonal influence on the effect of mirabegron treatment for overactive bladder. Issue 12 (December 2016) Authors: Kallner, Helena Kopp; Elmér, Caroline; Andersson, Karl-Erik; Altman, Daniel Journal: Menopause Issue: Volume 23:Issue 12(2016) Page Start: 1303 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Hormonal influence on the effect of mirabegron treatment for overactive bladder. Issue 12 (December 2016) Authors: Kallner, Helena Kopp; Elmér, Caroline; Andersson, Karl-Erik; Altman, Daniel Journal: Menopause Issue: Volume 23:Issue 12(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Intraprostatic injections for lower urinary tract symptoms treatment. Issue 1 (January 2015) Authors: Andersson, Karl-Erik Journal: Current opinion in urology Issue: Volume 25:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Intraprostatic injections for lower urinary tract symptoms treatment. Issue 1 (January 2015) Authors: Andersson, Karl-Erik Journal: Current opinion in urology Issue: Volume 25:Issue 1(2015:Jan.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Local versus intravenous injections of skeletal muscle precursor cells in nonhuman primates with acute or chronic intrinsic urinary sphincter deficiency. Issue 1 (December 2016) Authors: Williams, J.; Badlani, Gopal; Dean, Ashley; Lankford, Shannon; Poppante, Kimberly; Criswell, Tracy; Andersson, Karl-Erik Journal: Stem cell research & therapy Issue: Volume 7:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Melatonin Improves Erectile Function in Rats with Chronic Lower Body Ischemia. Issue 2 (1st February 2016) Authors: Sawada, Norifumi; Nomiya, Masanori; Zarifpour, Mona; Mitsui, Takahiko; Takeda, Masayuki; Andersson, Karl-Erik Journal: Journal of sexual medicine Issue: Volume 13:Issue 2(2016) Page Start: 179 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗